BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scherma M, Satta V, Collu R, Boi MF, Usai P, Fratta W, Fadda P. Cannabinoid CB1 /CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia. Br J Pharmacol 2017;174:2682-95. [PMID: 28561272 DOI: 10.1111/bph.13892] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Fearby N, Penman S, Thanos P. Effects of Δ9-Tetrahydrocannibinol (THC) on Obesity at Different Stages of Life: A Literature Review. Int J Environ Res Public Health 2022;19:3174. [PMID: 35328862 DOI: 10.3390/ijerph19063174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ceccarini MR, Precone V, Manara E, Paolacci S, Maltese PE, Benfatti V, Dhuli K, Donato K, Guerri G, Marceddu G, Chiurazzi P, Dalla Ragione L, Beccari T, Bertelli M. A next generation sequencing gene panel for use in the diagnosis of anorexia nervosa. Eat Weight Disord 2021. [PMID: 34822136 DOI: 10.1007/s40519-021-01331-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lowe H, Toyang N, Steele B, Bryant J, Ngwa W. The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases. Int J Mol Sci 2021;22:9472. [PMID: 34502379 DOI: 10.3390/ijms22179472] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
4 Coronado-Álvarez A, Romero-Cordero K, Macías-Triana L, Tatum-Kuri A, Vera-Barrón A, Budde H, Machado S, Yamamoto T, Imperatori C, Murillo-Rodríguez E. The synthetic CB1 cannabinoid receptor selective agonists: Putative medical uses and their legalization. Prog Neuropsychopharmacol Biol Psychiatry 2021;110:110301. [PMID: 33741446 DOI: 10.1016/j.pnpbp.2021.110301] [Reference Citation Analysis]
5 Scharner S, Stengel A. Animal Models for Anorexia Nervosa-A Systematic Review. Front Hum Neurosci 2020;14:596381. [PMID: 33551774 DOI: 10.3389/fnhum.2020.596381] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
6 Pucci M, Zaplatic E, Micioni Di Bonaventura MV, Micioni Di Bonaventura E, De Cristofaro P, Maccarrone M, Cifani C, D'Addario C. On the Role of Central Type-1 Cannabinoid Receptor Gene Regulation in Food Intake and Eating Behaviors. Int J Mol Sci 2021;22:E398. [PMID: 33401515 DOI: 10.3390/ijms22010398] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Hurel I, Muguruza C, Redon B, Marsicano G, Chaouloff F. Cannabis and exercise: Effects of Δ9-tetrahydrocannabinol on preference and motivation for wheel-running in mice. Prog Neuropsychopharmacol Biol Psychiatry 2021;105:110117. [PMID: 32971218 DOI: 10.1016/j.pnpbp.2020.110117] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Murphy T, Le Foll B. Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs. Biomolecules 2020;10:E855. [PMID: 32512776 DOI: 10.3390/biom10060855] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
9 D'Addario C, Zaplatic E, Giunti E, Pucci M, Micioni Di Bonaventura MV, Scherma M, Dainese E, Maccarrone M, Nilsson IA, Cifani C, Fadda P. Epigenetic regulation of the cannabinoid receptor CB1 in an activity-based rat model of anorexia nervosa. Int J Eat Disord 2020;53:432-46. [PMID: 32275093 DOI: 10.1002/eat.23271] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Collu R, Post JM, Scherma M, Giunti E, Fratta W, Lutz B, Fadda P, Bindila L. Altered brain levels of arachidonic acid-derived inflammatory eicosanoids in a rodent model of anorexia nervosa. Biochim Biophys Acta Mol Cell Biol Lipids 2020;1865:158578. [PMID: 31778792 DOI: 10.1016/j.bbalip.2019.158578] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
11 Scolnick B. Antihistamine agents and pitolisant might be useful for anorexia nervosa. Medical Hypotheses 2019;132:109342. [DOI: 10.1016/j.mehy.2019.109342] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Ogden SB, Malamas MS, Makriyannis A, Eckel LA. The novel cannabinoid CB1 receptor agonist AM11101 increases food intake in female rats. Br J Pharmacol 2019;176:3972-82. [PMID: 31328790 DOI: 10.1111/bph.14797] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Collu R, Scherma M, Piscitelli F, Giunti E, Satta V, Castelli MP, Verde R, Fratta W, Bisogno T, Fadda P. Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa. Int J Eat Disord 2019;52:1251-62. [PMID: 31456239 DOI: 10.1002/eat.23157] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
14 Schalla MA, Stengel A. Activity Based Anorexia as an Animal Model for Anorexia Nervosa-A Systematic Review. Front Nutr 2019;6:69. [PMID: 31165073 DOI: 10.3389/fnut.2019.00069] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 7.7] [Reference Citation Analysis]
15 Leszczynski EC, Visker JR, Ferguson DP. The Effect of Growth Restriction on Voluntary Physical Activity Engagement in Mice. Medicine & Science in Sports & Exercise 2019;51:2201-9. [DOI: 10.1249/mss.0000000000002040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
16 Støving RK. MECHANISMS IN ENDOCRINOLOGY: Anorexia nervosa and endocrinology: a clinical update. Eur J Endocrinol 2019;180:R9-R27. [PMID: 30400050 DOI: 10.1530/EJE-18-0596] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
17 Scolnick B. Hypothesis: Clues From Mammalian Hibernation for Treating Patients With Anorexia Nervosa. Front Psychol 2018;9:2159. [PMID: 30483182 DOI: 10.3389/fpsyg.2018.02159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Bonini SA, Premoli M, Tambaro S, Kumar A, Maccarinelli G, Memo M, Mastinu A. Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. J Ethnopharmacol 2018;227:300-15. [PMID: 30205181 DOI: 10.1016/j.jep.2018.09.004] [Cited by in Crossref: 145] [Cited by in F6Publishing: 120] [Article Influence: 36.3] [Reference Citation Analysis]
19 Scolnick B. Treatment of anorexia nervosa with palmitoylethanoamide. Med Hypotheses 2018;116:54-60. [PMID: 29857912 DOI: 10.1016/j.mehy.2018.04.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Horn H, Böhme B, Dietrich L, Koch M. Endocannabinoids in Body Weight Control. Pharmaceuticals (Basel) 2018;11:E55. [PMID: 29849009 DOI: 10.3390/ph11020055] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
21 Scherma M, Satta V, Collu R, Boi MF, Usai P, Fratta W, Fadda P. Cannabinoid CB1 /CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia. Br J Pharmacol 2017;174:2682-95. [PMID: 28561272 DOI: 10.1111/bph.13892] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]